대한의생명과학회지 (Biomedical Science Letters)

  • 제18권1호
  • /
  • Pages.76-78
  • /
  • 2012
  • /
  • 1738-3226(pISSN)
  • /
  • 2288-7415(eISSN)
대한의생명과학회 (The Korean Society for Biomedical Laboratory Sciences)
권호 표지

Analysis of Single Nucleotide Polymorphism of MMP3 Gene in Korean Genome

  • Kim, Su-Mi (Department of Biology, Keimyung University) ;
  • Kim, Su-Won (Department of Biology, Keimyung University) ;
  • Yoo, Min (Department of Biology, Keimyung University)
  • 투고 : 2012.03.01
  • 심사 : 2012.03.31
  • 발행 : 2012.03.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

MMP3 (Matrix metalloproteinase-3) is an important gene in the development of cardiovascular and metabolic diseases. It is also reported that the genotype of MMP3 could be a factor for disease conditions. So, SNP analysis is a prerequisite to study MMP3 related diseases. However, statistical data or analytical reports of this gene in the Korean population is not available. We have employed PCR and ARMS technique to amplify the position of Lys45Glu which is located within chromosome 11q22.3 and exon 2. Genomic DNA were extracted from 201 people. We found that, 17 individuals had the wild homozygote type (W/W, 8%), 98 individuals had the SNP homozygote type (S/S, 49%), 86 had the heterozygote type (W/S, 43%). This study should facilitate research on the cause of cardiovascular diseases due to polymorphisms in the MMP3 gene and to develop further therapy at the genetic level.

키워드

참고문헌

  1. Baek SA, Yoo M. Tandem Repeats (CCTTT)n in the Promoter of iNOS Gene in Korean Genome. J Exp Biomed Sci. 2009. 15: 167-170.
  2. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002. 2: 161-174.
  3. Hojilla CV, Mohammed FF, Khokha R. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer. 2003. 89: 1817-1821.
  4. Kim SW, Yoo M. Association of UCP2 Polymorphisms with Type 2 Diabetes in Korean Subjects. J Exp Biomed Sci. 2008. 14: 239-242.
  5. Kim YH, Ha KY, Kil GMl, Choi KY. The differences in expression of matrix metalloproteinase-3 in Degenerative lumbar scoliosis and spinal stenosis. J Kor Orthop Assoc. 2005. 40: 209-215.
  6. Lee KO. A Study of Genetic Polymorphisms of HLA-class I and II Genes Using Polymerase Chain Reaction. J Exp Biomed Sci. 1998. 4: 11-25.
  7. Lim SJ, Shin KY, Jeon CK, Han KY, Kim BO. A study on matrix metalloproteinase-3 activity in blood serum of the diabetic patients. Oral Biol Res. 2000. 24: 79-90.
  8. Nam JH, Park KS. Single nucleotide polymorphisms of matrix metalloproteinase in Koreans. Kor J Genet. 2004. 26: 289-296.
  9. Poollanen PJ, Lehtimaki T, Ilveskoski E, Mikkelsson J, Kajander OA, Laippala P, Perola M, Goebeler S, Penttila A, Mattila KM, Syrjakoski K, Koivula T, Nikkari ST, Karhunen PJ. Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study. Atherosclerosis 2002. 164: 329-335.
  10. Reynolds JI, Meikle MC. Mechanisms of connective tissue matrix destruction in periodontitis. Periodontol. 1997. 14: 144-157.
  11. Tervonen T, Karjalainen K. Periodontal disease related to diabetic status. A pilot study of the response to periodontal therapy in type 1 diabetes. J Clin Periodontol. 1997. 24: 505-510.
  12. Ye S. Influence of Matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovas Res. 2006. 69: 636-645.